PTAB ends Kyle Bass IPRs targeting Acorda patents on Ampyra MS treatment with no findings of obviousness – IPWatchdog.com

Posted: Published on March 15th, 2017

This post was added by Dr Simmons

Zn8y Vm'v7ImIP,%f**I5I#%^Q8M3fO}Y}xDzv:HD~B*pV13vcI{;[ 6[uFGsPz`YiJvn1Xto@c17h*LO!CJRY %:8r= =&}"S QdRB/ND^&g A@T%veuZ/b)CxWFDO_ oMU9AMBy}!D,YuL*.v!t=OlVH]l a"1mWK& GI`Y A 1;P^q+*vTeMD5Qo_o]bRw +1/vsk )z~+KgQZKY}lJ:Zx2 S"s3{6O^bc lY7pDyGf]!>X4FKHm#(;Z7OOZf5[|8;P{r5D, ~;~XR:E / ]Mf%l`xPNb7kX+1quD'lf7AS,p8{e-0(+4 ,X$N(J!9j059cm{P+-19ZBQW |I]i'K?H+t[~}"/C ]w5=l[`.!@ :IH%Bv8IfHZ"(2(Pj5 'W'm8$f!mFKKeNag.QRCi (W4i !1*#:5bubb<;fsV[LNwo6{{+xw?Hd<~E"OOkwXCayYEhQay4j{ZA~nOpMQ`#|HBQYhc)&rBSPHAON6oj *l3odw]kW3vKF/L{wQ %xs_73bg{1fKB-S|xk4RENo@]K:/B*dfM.! L[aEksOI6}%^a07cwX.\9ZLgR !I (W]|?e{meiU!_G <3Y|#5*Y,V|oW>C#m4h_4j |QmaNpWpPi2]XV:Cu(" tZ|`^$-2!2|4E3BZv2q-zoAx2`gZ]1AI1&<0 q>K+T7EJS>a_W{Yb*k;J^BiN^'>_;_L VHf+;k_vN j&Wvh0ScWZcjtJj;j:<;2obpR3[5kCv"PSD**zrt|rS&O:}^:9N8g{Vx#0i "3jtmo4^ko?'b M(ic;$kyEBK"N>g ^trROK>R &7Re i1@+GA[|" 2?2ksp~N1Dk13%b'"@n'+1I=~{dt owS"!,"gy-N9KXre-eLIk!+)l/D]or9Bop64T1dPp?=g2 `OuggLdztByw&3;:}Y%~:;Z2h1+]oL<5C` D:]EVxHw$L1tE^__j]5|R'}oO|~$;|pnLXuJNpE)rxB3}2B{l&,s}^Dgs>`?l]Ue^D_)r_lAh?J?,N!uD t,dX^SQ_]xd9Dp<[3`dhq&{4*|IL-=bbYe>!^Z|+u:6'Uw[b6Zi()O1N)bnC6,X 99C+R MZoq80kROs1]wl f>lq?Yml.|W IT[e)rTI@!;V,LyM&4.A~LJ)L X82e iH; ^PT&R"4b!y@v{TIqDU"60SiLG0z9ScNsv@=(52q LEKZ BsN">edvQvJO,0FQlSl*S8Jn[KR)$jbXkdIT@/n),s^A-E3l>xvYA7TY7UhJ)n8]XA/ e|K|oM0@=R4tY&NWKs,*d_uib[Mt#w[b,P_6YSP5,:ve;{>.o%Mn,"2$bgXxv^Cx^J]JM%3ykclV).,hHse/[nz8-^~_N?{*y5q5jOT 8]-0:[pHnSf-^XR"K3WF|M{0|C# @GsT:-)V ]T/&^x|r>5my,4Q.N"[ W${|G(;w 7lYd74dYGh*A/,Fn1=#A8.:lRivK`}:Mu>HN4]m; -v:Te~Wx&xm00RNL4$"w!B9vU,T*>0SY^l-8 pQjjnuHM,t[p7q7X9INjR>TaJ3B>p+{41zz FT'JB#,=*2Xz3dte3Vz1XD`as+xOu0?/skcX\ l8kL M,IHGVv/I*`4;Aj9)MN@$(6=' .@z"&c{Yw&+7aU]Fe0*m`E$=m2+19`Dq|zM.wa+**2gvdV.>-gKs?1;g0"HOd7V:|wyhL#!6eXOc!1a1-`ob V!?<*d#,q@"#pC,3@x^Onm?MqLC)eL jN<;kiF)05*p&g"{Ru4[7o ?cropzBMA 8 "$`6ZQWf[Y(:!z CNdxA0EewSB"Bfh?o-dW({g. v&i}P=7c&^y@;{#Ic~"$c_]it~^F?goVG`6g>527v"k28Bm35}loeczPe1/eyDXwVW7ZR&5c}zU !Kc^B}ucd@^o@H4.{uD7D hm:z6eKA[D4)Abz1 prF,eU ]e'cOdk,r&,:<8 #BTrMy-GO7UO7ja'<+ %FE1 z-mDIVJO76sVV|F[rk:u^}UcY4t_ P W 0V({pAbtL7/]C9J/>/ybq&Z}%V-nln95wHY(G[*0b@6 @S6AI>Cy(@$w||iMh]Vt@+XqU*Xy{^/} [P[*Q;jH#poO7=sztm4343F}aaUeX+Lm7KZ}"|,T{ Vb`Nks.jE8n,1bhX2]?C9YA`>%X m/Bp!vXH3) xo8T5JQau5+ c3h&,v_FA8N"vEe>iyaaIIOWJ'aRiW: Hg)2y{0W<)ZTNp:o.o"9)[! ]l5#)'|3R~0!&0$U_me*S?,e^^m^nzXS99k$Ll/ 2Pux5W_:7zfU4ISC8ns1%V@r|i%U)-L4kc."a!YQn'KB(2a'*<9MODDK2H`m"Vg&0y:-hNV%^yz#SgCF0jT%#9p `s<4M Lo9]!=^pt&lzEYd^hld|yK @lX]wXx0i9f/dK$aVxVdMRa:1qR" .D$P4nVYiNuvgMX4Tgl4 Tc[5L"[NNN],2odL#J/%mef/F>AP+>Ep1pDP_y[aEP7~NW"{!ib&"}YWH5]EcYvfoi?qV#3?o`{OTxe(X4NW_8G$4="LM^=)KO[K-~:LxyLMlU+nbdIJ:+qO@"fi~-4 1Bf'O FY.eE/V:X4(y4B mf'?.huLkkFJEJML'6lH;77z#;4/n)dU&iNF,2)7SHH4dVBtL)@`p(CdJ><]K9@L7W~x[<]xi>1w

Excerpt from:
PTAB ends Kyle Bass IPRs targeting Acorda patents on Ampyra MS treatment with no findings of obviousness - IPWatchdog.com

Related Posts
This entry was posted in MS Treatment. Bookmark the permalink.

Comments are closed.